BARR

📅 Upcoming

🕒 Recent(90d)

News

• Goa Therapeutics launches with ‘immeasurably huge’ vision of creating Narcan for alcohol
  A new biotech has sprung out of stealth with a bold vision to develop the “greatest therapeutic of all time”—a drug that can quickly sober up people who have had too much to drink.
  fiercebiotech · 3d ago
• North Immunology goes public via reverse merger as eczema drug heads toward clinic
  North Immunology has decided its path to taking an atopic dermatitis drug into the clinic involves going public via a reverse merger.
  fiercebiotech · 3d ago
• AZ's R&D chief Barr touts internal 'science success story' after IL-33 antibody's stellar showing in COPD
  With a detailed data drop that AstraZeneca’s R&D chief describes as an internal “science success story,” the British Big Pharma has secured an FDA priority review for what it believes could become…
  fiercebiotech · 12d ago
• AstraZeneca, Amgen notch another late-stage win for Tezspire, this time in esophagitis
  AstraZeneca and Amgen co-develop and co-commercialize Tezspire under an April 2012 agreement. The partners are now planning another FDA submission for the asthma drug, which received an expansion i…
  biospace · 24d ago
• Opinion: Climate change is making people with chronic illness even sicker
  “What research can definitively tell us is that climate change is here, and it’s already making people sick,” writes Lorraine Boissoneault.
  stat · 1mo ago
• Covid can reactivate dormant viruses, according to study
  A CDC director officially confirmed, Moderna's mRNA flu shot approved, and other health news from Morning Rounds
  stat · 1mo ago
• STAT+: FDA approves Merck’s oral PCSK9 drug, a first
  Kalshi allows bets on clinical trial outcomes, Eli Lilly buys a psychedelic medicine, and more biotech news from The Readout
  stat · 2mo ago
• STAT+: CMS signals intent to revamp how it pays for clinical software and AI
  CMS wants to build a standardized payment structure for clinical software and AI that factors in their impact on patient outcomes.
  stat · 2mo ago
• STAT+: New study untangles how Epstein-Barr viral infection triggers immune response in multiple sclerosis
  A new study claims to have uncovered how Epstein-Barr virus launches immune responses seen in people with multiple sclerosis.
  stat · 2mo ago
• FDA Approves New Indication for Tzield (teplizumab) for Certain Pediatric Patients with Recently Diagnosed Stage 3 Type 1 Diabetes
  On June 12, 2026, the U.S. Food and Drug Administration granted accelerated approval to Tzield (teplizumab) for a new indication, to delay the decline of insulin production in pediatric patients ag…
  fda_press · 3mo ago